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While there is a considerable amount of evidence that
signal transduction by the growth hormone (GH) recep-
tor requires receptor homodimerization, there has been
no systematic study of the role of receptor dimerization
domain residues in this process. In conjunction with the
distances derived from the crystal structure of the hGH-
hGH receptor (extracellular domain) complex, we have
used a luciferase-based c-fos promoter reporter assay in
transiently transfected Chinese hamster ovary (CHO)
cells, and stable receptor expressing CHO cell popula-
tions to define the dimerization domain residues needed
for effective signaling. In addition to alanine substitu-
tion, we have used both aspartate and lysine substitu-
tions to allow us to provide evidence for proximity rela-
tions through charge complementation. Introduced
cysteine substitutions were also used, but unlike the
erythropoietin receptor, these were unable to generate
constitutively active receptor. We conclude that serine
145, histidine 150, aspartate 152, tyrosine 200, and serine
201, but not leucine 146 or threonine 147 are required
for effective signal transduction through the dimeriza-
tion domain. This information may be valuable in de-
signing small molecule antagonists of GH and other cy-
tokines that block dimerization by binding to the
dimerization domain.
Dimerization of receptors induced by ligand binding is a
common means of triggering signal transduction in mamma-
lian cells (1). In a number of members of the tyrosine kinase
receptor family (e.g. platelet-derived growth factor and epider-
mal growth factor), two ligand molecules bind to two receptors
to form a L2R2 complex, which is followed by activation of the
receptor tyrosine kinase. By contrast, in the cytokine receptor
superfamily, one ligand molecule promotes dimerization of het-
erologous receptor subunits or dimerization of two identical
subunits (2, 3). Currently, the best characterized example of
ligand-induced receptor dimerization in the cytokine receptor
superfamily is the GH receptor (GHR).1 The crystal structure
of the ligand-bound complex (4) shows that hGH binds to two
identical receptor (hGHBP) subunits to induce receptor dimer-
ization, which is aided by a dimerization domain in the C-
terminal b sandwich (domain 2). Eight residues were identified
as being involved in this dimerization domain, and the rela-
tionship of these is summarized in Table I. The crystal struc-
ture verified previous studies based on several techniques,
which demonstrated a 1:2 stoichiometry of hormone to receptor
(5). GHR dimerization occurs sequentially, i.e. hGH binds to
the first hGHR through “site 1” of hGH and subsequently binds
to the second hGHR through “site 2” of hGH (5). Cunningham
et al. (5) proposed that receptor dimerization results in signal
transduction, and this proposal was verified by studies from
the same group with GH mutants and GH receptor monoclonal
antibodies using a proliferation assay for FDC-P1 cells express-
ing a chimeric hGH-mouse granulocyte colony-stimulating fac-
tor receptor (6). A study of GH-induced tyrosine phosphoryla-
tion of cellular proteins also showed that tyrosine
phosphorylation was inhibited by treating IM-9 cells with a GH
mutant that prevents receptor dimerization (7). Furthermore,
a mathematical model for the quantitative evaluation of the
bell-shaped dose-response curves associated with sequential
receptor dimerization and the use of the nondimerizing hGH
mutant (G120R)2 indicated that GHR dimerization is essential
for GH stimulation of both lipogenesis in primary rat adipo-
cytes and receptor down-regulation in cultured human IM-9
lymphocytes (8). In support of these studies, a single amino
acid substitution (D152H) in the dimerization region of the
human GHR identified in a Laron dwarf abolished receptor
dimerization (9). GHR dimerization is thought to activate Jak2
kinase, which then phosphorylates both the receptor and down-
stream signaling components such as the Stats, IRS-1 and Shc
(10). Currently, no systematic study of the importance of re-
ceptor dimerization domain residues in signal transduction has
been carried out by biological function assay. In addition, it is
not proven that those residues involved in dimerization in the
crystal structure indeed represent residues interacting in situ.
Accordingly, eight residues in the putative dimerization region
of RGHR (based on the crystal structure of hGHBP; Ref. 4)
were converted to alanine, to cysteine, to lysine, and to aspar-
tate individually or in combination, and the importance of
these residues in signal transduction was examined using a
c-fos promoter luciferase assay (11) which has been useful in
defining structural components of the receptor needed for
signaling (12).
MATERIALS AND METHODS
Constructs
Receptor Dimerization Domain Mutants—A rabbit GHR (RGHR) ex-
pression plasmid (pECE-RGHR) was constructed by inserting rabbit
growth hormone receptor (RGHR) cDNA (13) into the SV40-based mam-
malian expression vector pECE at KpnI and XbaI sites. All RGHR
mutants were inserted into the mammalian expression vector pECE as
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for wild type pECE-RGHR. The following mutations were made by
oligonucleotide-mediated mutagenesis using the Altered Sites in vitro
mutagenesis system (Promega) with pSELECT and approximately 30
bp of oligonucleotides incorporating 1–3 altered bases, synthesized on a
Milligen/Biosearch 7500 DNA synthesizer, and purified by polyacryl-
amide gel electrophoresis. Multiple alanine substituted mutants were
made with the following oligonucleotides: 59-G ACT TTA CTGGCTGTT
GCC GCA GCC GGG ATT GCT GCA GCT ATT CAA GTG C-39 for
A143/A145/A146/A147/A150/A152 (6 Ala); 59-CT GTA TTG TCG ACA
TCA GTT CCT GTG GCC GCG TTA AG-39 for A200/A201; 59-CCT GTA
TTG TCG ACA TCA GTT CCT GTG TAC GCG TTA-39 for S201A;
59-GTT AGC TTA ACC GGG ATT GCT GCA GCT ATT CAA G-39 for
A150/A152. Eight Ala, 4 Ala, and 3 Ala mutants were made by combin-
ing these primers, to give the particular Ala substitutions given below.
pECE-RGHR-8A—In this construct, 8 residues in the extracellular
region identified in the crystal structure as interacting across the
dimerization domain (asparagine 143, serine 145, leucine 146, threo-
nine 147, histidine 150, aspartate 152, tyrosine 200, and serine 201)
were converted to alanine.
pECE-RGHR-6A—In this construct, 6 residues (asparagine 143, ser-
ine 145, leucine 146, threonine 147, histidine 150, and aspartate 152)
were converted to alanine.
pECE-RGHR-4A—For this construct, 4 residues (histidine 150, as-
partate 152, tyrosine 200, and serine 201) were converted to alanine.
pECE-RGHR-3A—Here, 3 residues (histidine 150, aspartate 152,
and serine 201) were converted to alanine.
pECE-RGHR-Y200,S201A (RGHR-200,201A)—In this construct, 2
residues (tyrosine 200 and serine 201) were converted to alanine.
Other Constructs—Other constructs created with the Altered Sites
system were: pECE-RGHR-S201A, pECE-RGHR-S145C, pECE-RGHR-
D152C, pECE-RGHR-Y200C, pECE-RGHR-S201C, pECE-RGHR-
152,200C, pECE-RGHR-L146D, pECE-RGHR-H150D, pECE-RGHR-
Y200D, pECE-RGHR-S201D, pECE-RGHR-N143K, pECE-RGHR-
S145K, pECE-RGHR-L146K, pECE-RGHR-T147K, pECE-RGHR-
H150K, pECE-RGHR-D152K, pECE-RGHR-S201K, pECE-RGHR-
H150K, D152K(RGHR-150, 152K), and pECE-RGHR-Y200,S201K
(RGHR-200,201K). All constructs were verified by double-strand
dideoxy sequencing using the Pharmacia T7 kit.
c-fos Luciferase Reporter Construct—Plasmid pfos 396D219–81 was
constructed by inserting the fragment of the human c-fos promoter from
2396 to 142 into pGL.Basic after deleting the 138 bp from 2219 to 281
(11).
Cell Culture
Transient Transfection of CHO K1 Cells—This was undertaken as for
Chen et al. (11). Briefly, CHO K1 cells maintained in 2 ml of Ham’s F-12
medium containing 5% FCS were dispensed into six-well plates at 2.2 3
105 cells/well and left for 20–24 h. After aspiration of the medium, 160
ml of transfection reagent-DNA mixture containing 1 mg of receptor
mutant expression plasmid, 2 mg of reporter gene, and 20 ml of DOTAP
in HBS (20 mM Hepes, 150 mM NaCl, pH 7.4) was added to each well
and mixed gently for 30 s. Three ml of Ham’s F-12 medium containing
0.5% FCS was then added to each well. After incubation for 40 h,
transfected cells were treated with 200 ng/ml rhGH. Negative control
cells were treated with the same volume of serum-free Ham’s F-12
medium (medium control). After further incubation for 5.5 h, the cells
were harvested for luciferase assay according to Promega’s instructions,
and normalized to protein content. Constructs were transfected in trip-
licate for each experiment, and all experiments were repeated a mini-
mum of three times. Transfection controls were as described in Ref. 11,
and always included wild type receptor.
Stable Transfection of CHO K1 Cells—CHO K1 cells maintained in 2
ml of Ham’s F-12 medium containing 5% FCS were dispensed into
six-well plates at 2.2 3 105 cells/well and left for 20–24 h. After aspi-
ration of the medium, 160 ml of transfection reagent-DNA mixture
containing 2.7 mg of wild type or mutant RGHR expression plasmid, 0.3
mg of NeoR expression plasmid, and 20 ml of DOTAP in HBS (20 mM
Hepes, 150 mM NaCl, pH 7.4) was added to each well and mixed gently
for 30 s. Two ml of Ham’s F-12 medium containing 0.5% FCS was then
added to each well. After incubation for 16 h, the culture medium was
changed to 3 ml of Ham’s F-12 medium containing 10% FCS, and the
cells were incubated for an additional 48–72 h. Stable transfectants
were selected by including G418 in the cell culture medium at 300 ng/ml
until the surviving cells reached clonal confluence. The surviving clones
were then selected and cultured. An aliquot of each clone was stored
frozen, while the reminder of the cells were used for analyses.
Hormone Binding Analysis
Hormone binding constants for cell surface receptor mutants were
determined by Scatchard assay using recombinant human GH (a gift
from Genentech Inc., South San Francisco, CA) with receptor mutants
stably expressed as populations in CHO-K1 cells, since it was not
possible to measure receptor transiently expressed, as in the luciferase
assay. GH was radiolabeled by the IODOGEN method (14) following by
separation on a Sephadex G100 column to give a specific activity range
of 100–150 mCi/mg. For assays, 2 3 105 cpm iodinated hormone (less
than 1 week old) and eight concentrations (0, 3, 10, 30, 50, 100, 1000,
and 10,000 ng/ml) of unlabeled competitor in triplicate were added to
cultured cells transfected with wild type or mutant GH receptor. CHO
K1 cells stably expressing wild type or mutant RGHR were grown to
confluence in six-well plates. Medium was then changed to 25 mM
Tris-HCl (pH 7.5), 130 mM NaCl, 0.1% BSA, and 20 mM MgCl, and the
assay was carried out essentially as in Ref. 15. After incubation at 10 °C
for 16 h, the CHO K1 cells were washed with ice-cold phosphate-
buffered saline and harvested by addition of 1 ml of 0.1 M NaOH and
incubation for 15 min at room temperature. At 10 °C, internalization is
minimal, and the cell membrane is in a highly ordered, gel phase (27).
Cell surface-associated counts were quantified using an LKB 1275 g
counter. The resulting data were analyzed and the binding constants
calculated using the McPherson LIGAND program (Elsevier Biosoft).
Scatchard plots are linear below 50 pM receptor concentration for a
dimerizing GH receptor (8), and all estimations herein gave linear
Scatchard plots and receptor concentrations below 30 pM.
RESULTS
Alanine Substitutions—Alanine substitution (scanning) is
minimally perturbing for secondary and tertiary structure and
is generally regarded as the best means of selective removal of
interactive residues involved in salt bridges and hydrogen
bonds (16, 17). To confirm that alanine-substituted RGHRs
were expressed correctly, and to define any impairment of
ligand binding, Scatchard assays were performed with stable
CHO K1 transfectants. These showed that pECE-RGHR-8A,
pECE-RGHR-6A, and pECE-RGHR-S201A were expressed
with wild type RGHR affinity and at comparable levels, al-
though pECE-RGHR-8A was expressed at only 28% of wild
type number (Table II). These data indicate that alanine mu-
tation in the dimerization domain has no effect on binding
affinity of RGHR, and that receptor was expressed at an ac-
ceptable level. Fig. 1A shows that in the transient cotransfec-
tion assay, induction of luciferase activity by GH with pECE-
RGHR-8A, pECE-RGHR-6A, pECE-RGHR-4A, pECE-RGHR-
3A, and pECE-RGHR-200,201A was less than 25% of wild type
pECE-RGHR, and for pECE-RGHR-S201A was 67 6 4% that of
wild type. These results indicate that the residues in the dimer-
ization region observed from crystal structure are indeed in-
volved in signal transduction, particularly Tyr-200 and His-
150/Asp-152. Moreover, although the alanine mutants pECE-
RGHR-8A, pECE-RGHR-6A, pECE-RGHR-4A, and pECE-
RGHR-3A exhibited reduced induction of luciferase activity by
GH, they exhibited significantly higher (over 2-fold) basal ac-
tivity than wild type RGHR (Fig. 1B). Therefore, it is possible
that these alanine mutants are actually facilitating dimeriza-
tion through hydrophobic interaction.
Cysteine Substitutions—The homologous erythropoietin re-
ceptor is able to exhibit constitutive activation through disul-
fide bond-initiated homodimerization in the R129C erythroleu-
kemia mutation (18), and also in E132/133C putative
dimerization domain mutants (19). To investigate whether an
analogous constitutive activation of the GH receptor could be
obtained, we substituted four dimerization domain residues
(Ser-145, Asp-152, Tyr-200, and Ser-201) with cysteine, and we
also created a double cysteine mutant (pECE-RGHR-
D152C,Y200C). As indicated in Table I, the latter two residues
appear to be hydrogen-bonded in the crystal structure. These
mutants were found to be expressed with essentially wild type
affinity in CHO-K1 stable populations, and at levels from 76 to
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278% of wild type (Table II). However, transient transfection
assay showed that basal luciferase activities were similar to
that of wild type RGHR with all of these cysteine mutants,
ranging from 79% (pECE-RGHRS145C) to 115% (pECE-
RGHRS201C) of wild type (Fig. 2B). Cysteine substitution of
Ser-145 almost abolished GH induction of luciferase, exhibiting
just 5.3 6 2.9% (mean 6 S.E.) the activity of wild type RGHR
(Fig. 4). GH induction with pECE-RGHR-D152C, pECE-
RGHR-Y200C, pECE-RGHR-S201C, and pECE-RGHR-
152,200C was 12 6 3%, 42 6 5%, 64 6 10%, and 10 6 2.0% that
of wild type RGHR, respectively (Fig. 2A). Accordingly, these
substitutions further support the important role of dimeriza-
tion domain residues (particularly Ser-145 and Asp-152) in
signal transduction, but provide no evidence of constitutive
activation of the receptor.
Aspartate Substitutions—Charge reversal is a useful tool for
defining interactive residues (20–22). Conversion of residues in
the dimerization region of RGHR to aspartic acid should abro-
gate dimerization by repulsion unless divalent cations shield
these negative charges (21). Accordingly, four dimerization do-
main residues (leucine 146, histidine 150, tyrosine 200, and
serine 201) were converted to aspartic acid. Scatchard analysis
of stable CHO K1 populations expressing these mutant recep-
tors showed that hormone affinity was not significantly differ-
ent from wild type RGHR, and cell surface receptor expression
ranged from 38–80% of wild type (Table II). Inductions of
luciferase activity by GH with pECE-RGHR-L146D, pECE-
RGHR-H150D, pECE-RGHR-Y200D, and pECE-RGHR-S201D
were 90 6 5%, 11 6 3%, 27 6 3.3%, and 13 6 4% that of wild
type RGHR, respectively (Fig. 3A). Wild type RGHR and the
four aspartic acid mutants had similar basal luciferase activity
(Fig. 3B). These data support a role for His-150, Tyr-200, and
Ser-201 in the dimerization process, but not Leu-146.
Lysine Conversions—As in the case of aspartic acid, substi-
tution of dimerization domain residues with lysine would be
expected to inhibit dimerization by charge repulsion. Accord-
ingly, 8 residues (asparagine 143, serine 145, leucine 146,
threonine 147, histidine 150, aspartate 152, tyrosine 200, and
serine 201) were converted to lysine. With the exception of
Ser-145, hormone affinity did not differ from wild type in stable
transfectants (Table II). As in the case of the cysteine mutant
TABLE I
Salt bridges and hydrogen bonds across the dimerization domain (4)
hGHBP I
atom
hGHBP II
atom Distance
Å
Ser145Og Asp152Od2 3.0
Leu146N Ser201Og 3.1
Thr147Og Asp152Od1 2.7
His150Ne2 Asn143Od1 2.9
Asp152Od2 Tyr200Oh 2.7
Ser201Og Tyr200Oh 3.3
TABLE II
Binding affinity and number of wild type and mutated RGHR
Constructs Binding affinity No. ofRGHR/cell
No. of wild
type RGHR
3 10210 M21 %
pECE-RGHR 1.50 6 0.3 3485 6 63 100
pECE-RGHRN143K 1.37 6 0.176 2544 6 48 73
pECE-RGHRS145C 0.72 6 0.09 9696 6 3677 278
pECE-RGHRS145K 0.59 6 0.11 5148 6 1260 148
pECE-RGHRL146D 1.43 6 0.6 1680 6 529 48
pECE-RGHRL146K 1.31 6 0.2 6048 6 1660 173
pECE-RGHRT147K 1.24 6 0.38 2640 6 629 76
pECE-RGHRH150D 1.08 6 0.13 2088 6 615 60
pECE-RGHRD152C 1.48 6 0.09 2640 6 635 76
pECE-RGHRD152K 1.58 6 0.02 1872 6 680 54
pECE-RGHRY200C 1.30 6 0.1 3936 6 584 113
pECE-RGHRY200D 1.24 6 0.26 1320 6 433 38
pECE-RGHRS201A 1.50 6 0.4 3024 6 144 87
pECE-RGHRS201C 1.05 6 0.28 3864 6 536 111
pECE-RGHRS201D 0.98 6 0.17 2790 6 641 80
pECE-RGHRS201K 1.30 6 0.3 1920 6 584 55
pECE-RGHR150,152K 0.88 6 0.14 1872 6 72 54
pECE-RGHRH150D plus
pECE-RGHRD152K
1.13 6 0.18 1656 6 288 48
pECE-RGHRS201D plus
pECE-RGHRS201K
1.24 6 0.17 3600 6 831 103
pECE-RGHRY200D plus
pECE-RGHR150,152K
1.40 6 0.1 864 6 288 25
pECE-RGHR8A 1.30 6 0.1 986 6 561 28
pECE-RGHR6A 1.41 6 0.3 2160 6 216 62
FIG. 1. A, comparison of alanine mutants and wild type RGHR in the
induction of luciferase activity by GH. 1 mg/well of wild type RGHR or
alanine mutant plasmids with 2 mg/well c-fos reporter plasmids were
co-transfected into CHO K1 cells in six-well plates. After a 40-h incu-
bation in Ham’s F-12 medium containing 0.5% FCS, the cells were
treated with 200 ng/ml GH for 5.5 h as described under “Materials and
Methods.” Data are means 6 S.E. of three or four independent trans-
fection experiments, and are expressed as a percentage of wild type
RGHR induction. **, p , 0.01, by ANOVA with Tukey’s multiple range
comparison. B, comparison of basal luciferase activity of wild type
RGHR and alanine mutants. All values of basal luciferase activity of
alanine mutants were normalized to a basal luciferase activity of 100%
for wild type RGHR. GH inductions for wild type RGHR and alanine
mutants were similarly normalized. Data are means 6 S.E. *, p , 0.05;
**, p , 0.01 by ANOVA with Tukey’s multiple range test.
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RGHR-S145C, the binding affinity of RGHR-S145K was some-
what lower than that of wild type RGHR (39%), which may
indicate a minor contribution to hormone binding, presumably
indirectly through the b sandwich. Receptor expression in
these stable populations ranged from 54 to 173% of wild type
(Table II). Fig. 4A shows that pECE-RGHR-L146K and pECE-
RGHR-T147K gave essentially wild type induction of luciferase
activity by GH and pECE-RGHR-N143K showed minor loss of
inducibility, while pECE-RGHR-S145K, pECE-RGHR-H150K,
pECE-RGHR-D152K, pECE-RGHR-S201K, pECE-RGHR-
150,152K, and pECE-RGHR-200,201K showed clearly reduced
induction, particularly the last three mutants. This indicates
that substitution of asparagine 143, leucine 146, and threonine
147 with lysine has little effect on signal transduction to c-fos,
whereas again Ser-145, His-150, Asp-152, and Tyr-200/Ser-201
are needed for effective signaling. Interestingly, pECE-
RGHRN143K displayed a significantly higher basal luciferase
activity (264 6 4% of wild type RGHR), although basal expres-
sion of other lysine mutants was normal (Fig. 4B).
Combination of Aspartate and Lysine Conversions—Taken
together, these alanine, cysteine, aspartic acid, and lysine mu-
tations indicate that particular dimerization domain residues
are involved in signal transduction by the RGHR. However, the
decrease in induction of luciferase activity by GH with these
mutants could also result from a less specific perturbation in
conformation in the C-terminal domain of the RGHR extracel-
lular region, which affects signal transduction but not binding
affinity. Therefore, to verify whether these residues are directly
involved in dimerization, and to gain information about prox-
imities of important dimerization domain residues, charge
complementation studies (20) were undertaken. Plasmids en-
coding negatively charged mutants (pECE-RGHR-H150D,
pECE-RGHR-Y200D, and pECE-RGHR-S201D) and positively
charged mutants (pECE-RGHR-S145K, pECE-RGHR-L146K,
pECE-RGHR-H150K, pECE-RGHR-D152K, pECE-RGHR-
S201K, pECE-RGHR-150,152K, and pECE-RGHR-200,201K)
were either transfected alone or co-transfected into CHO K1
cells with the c-fos reporter plasmid. The total amount of re-
ceptor expression plasmid was held constant, so that in the
absence of complementation, a value between the individual
values for single charge conversions would be predicted.
Complementation of induction through electrostatic pairing
would suggest that the decreased signaling observed when
each mutant is expressed alone is specifically a result of dis-
rupted dimerization.
Results with negatively charged mutants alone, and posi-
tively charged mutants alone or with both charge mutant com-
FIG. 2. A, comparison of cysteine mutants and wild type RGHR in the
induction of luciferase activity by GH. Protocol and analysis were as
described in Fig. 1A. B, comparison of basal luciferase activity of wild
type RGHR and cysteine mutants. Analysis was as described in Fig. 1B.
FIG. 3. A, comparison of aspartic acid mutants and wild type RGHR
in the induction of luciferase activity by GH. Protocol and analysis were
as described in Fig. 1A. B, comparison of basal luciferase activity of wild
type RGHR and aspartic acid mutants. Analysis was as described in
Fig. 1B.
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binations are summarized in Table III. These results showed
that signal transduction was partially restored (p , 0.05 to p ,
0.01) by charge complementarity between the 150/152 couple
(p , 0.05), the 201/201 couple (p , 0.01), and the 200/150–152
couple (p , 0.05). Weak complementation probably also occurs
between the 143/150 couple and the 200/201 couple, but not
among the remaining charge complementations. Since these
conclusions are based on the assumption that co-expressed
plasmids are expressed as the sum of each separately, we
tested this by co-transfecting three positive complementations
and measuring total cell surface expression by Scatchard anal-
ysis. Table II shows that for the 150/152 couple and the 201/201
couple, receptor expression resulting from co-transfection is not
significantly different from the sum of separate expressions.
However, expression of cotransfected pECE-RGHR-Y200D and
pECE-RGHR-150,152K is somewhat less than either construct
alone; the effect of this will be to minimize the observed
complementation.
DISCUSSION
It has been demonstrated that GH binding leads to dimer-
ization and receptor signaling (6), but with the exception of a
case of Laron dwarfism involving Asp-152 (9), the importance
of individual residues within the dimerization domain has not
been demonstrated. Indeed, to our knowledge, a mutagenic
analysis of known receptor dimerization domain residues
needed for signaling has not been carried out with any cytokine
receptor, although a study on four putative dimerization do-
main residues has been reported for the erythropoietin receptor
(19). Here we have shown that Ser-145, His-150, Asp-152,
Tyr-200, and Ser-201 constitute the important residues re-
quired for effective signal transduction to the c-fos promoter,
which integrates two of the major signaling pathways originat-
ing from the activated receptor: STAT (signal transducer and
activator of transcription) and mitogen-activated protein ki-
nases (11). We have also used a charge complementation ap-
proach derived from Barnard (20) to demonstrate that the loss
in signaling seen with mutated residues is not a result of
nonspecific conformational perturbation, and to demonstrate
proximity of certain of the dimerization domain residues in-
volved in signal transduction. Charge reversals have been used
successfully in the study of a number of protein-protein inter-
actions (e.g. Refs. 21 and 22).
Since the sequences of the rabbit and human GH receptors
are totally homologous within the dimerization domain (13),
in the ensuing discussion of individual interactions we shall
refer to the distances determined for the human (GHBP)2 hGH
complex (4).
In the crystal structure, the distance between the g oxygen
atom of serine 201 (receptor 1 or bp 1) and the h oxygen atom
of tyrosine 200 (bp 2) is 3.3 Å, and the distance between the g
oxygen atom of serine 201 (bp 2) and the nitrogen atom of
leucine 146 (bp 1) is 3.1 Å (Table I), indicating hydrogen bond-
ing. When serine 201 was converted to alanine, cysteine, as-
partic acid, or lysine, induction of luciferase activity by GH
with these mutants was 67%, 64%, 17%, and 11% that of wild
type RGHR, respectively, and induction of luciferase activity by
GH with pECE-RGHR-S201D and pECE-RGHR-S201K com-
bined was 33% that of wild type RGHR. These results show
that induction of luciferase activity by GH is greater when
there is no repulsion between two position 201 residues, which
means that proximity of both 201 residues is required for
effective signal transduction by the RGHR, and indeed, these
two residues are within salt bridge distance in the crystal
structure. Charge complementation did not fully restore sig-
naling, possibly because of steric hindrance in the dimerization
FIG. 4. A, comparison of lysine mutants and wild type RGHR in the
induction of luciferase activity by GH. Protocol and analysis were as
described in Fig. 1A. B, comparison of basal luciferase activity of wild
type RGHR and lysine mutants. Analysis was as described in Fig. 1B.
TABLE III
Charge complementation studies
Constructs Luciferaseinduction Constructs
Luciferase
induction
% %
RGHRwt 100 RGHRwt 100
H150D plus 150,152K 45 6 5a N143K plus H150D 62 6 4
H150D 11 6 3 N143K 67 6 9
150,152K 24.5 6 2 H150D 14 6 7
H150D plus D152K 49 6 7a L146K plus S201D 39 6 7
H150D 11 6 3 L146K 88 6 4
D152K 23 6 8 S201D 10 6 6
S201D plus S201K 33 6 3b H150K plus H150D 7 6 6
S201D 17 6 4 H150K 13.7 6 6
S201K 10 6 2 H150D 11 6 3
Y200D plus 150,152K 40 6 3a 200,201K plus
Y200D
30 6 4
Y200D 25 6 2 200,201K 10 6 4
150,152K 8 6 6 Y200D 32 6 5
Y200D plus D152K 39 6 3a S201K plus Y200D 17 6 2
Y200D 25 6 2 S201K 11 6 2
D152K 21 6 3 Y200D 20 6 2
a p , 0.05, values are mean 6 S.E.
b p , 0.01, values are mean 6 S.E.
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region or because not all transiently co-transfected cells ex-
pressed an equal amount of both constructs. The fact that
signaling with S201C was not constitutive may mean that an
additional hormone-induced conformational change is re-
quired, or that the disulfide bond did not form. Western blots of
cysteine-substituted stable CHO K1 populations obtained from
non-reduced, N-ethylmaleimide-extracted cells did not show
receptor dimer, but did show a large amount of immunoreactive
material at the stacking gel interface.3
In the crystal structure of the complex the h oxygen atom of
tyrosine 200 (bp 2) is 2.7 Å from the d2 oxygen atom of aspartic
acid 152 (bp 1) and 3.3 Å from the g oxygen atom of serine 201
(bp 1), and it is believed that tyrosine 200 forms an important
hydrogen bond stabilizing the receptor dimer (Table I and De
Vos et al. (4)). When tyrosine 200 was converted to cysteine and
aspartic acid, the induction of luciferase activity by GH were
42% and 24% that of wild type RGHR, respectively, without
significant change in hormone binding affinity. Furthermore,
induction of luciferase activity by GH with pECE-RGHR-
S201A and pECE-RGHR-200,201A was 67% and 21% that of
wild type RGHR, respectively. These results verify that tyro-
sine 200 is important for signal transduction by the RGHR but
has no significant effect on hormone binding affinity, as ex-
pected. In the case of Y200C, where the phenolic ring of tyro-
sine was replaced by a thiol group, conformational perturbation
or weakening of the hydrogen bond is expected, with minor loss
in signaling. However, in the case of Y200D, the mutant re-
sulted in repulsion between two aspartic acids, so induction of
luciferase activity by GH with pECE-RGHR-Y200D was lower
than that of pECE-RGHR-Y200C, even accounting for de-
creased expression of the aspartate mutant (Table II). Further
evidence for a role of tyrosine 200 in dimerization leading to
signaling came from the charge reversals. Combinations of
pECE-RGHR-150,152K with pECE-RGHR-Y200D and pECE-
RGHR-D152K with pECE-RGHR-Y200D led to a greater induc-
tion of luciferase activity by GH than with RGHR-150,152K,
pECE-RGHR-Y200D, and pECE-RGHR-D152K alone (Table
III). Interestingly, pECE-RGHR-200,201K with pECE-RGHR-
Y200D and pECE-RGHR-S201K with pECE-RGHR-Y200D did
not give a greater induction of luciferase activity by GH than
pECE-RGHR-200,201K, pECE-RGHR-Y200D, and pECE-
RGHR-S201K alone, respectively (Fig. 5). These results sug-
gested that tyrosine 200 interacts with aspartic acid 152 rather
than serine 201. This suggestion was also supported by the
minimal GH induction seen with the non-repulsive mutant
pECE-RGHR-152,200C (Fig. 2). It may be that the inability to
obtain constitutive activation with the pECE-RGHR152,200C
mutant is a result of an excessive distance between thiol groups
where disulfide bonds cannot be formed when the rigid b sheet
structures are aligned, or a result of formation of non-signaling
higher order polymers, as indicated above.
When aspartic acid 152 was converted to cysteine and to
lysine, induction of luciferase activity by GH was 12% and 23%
that of wild type RGHR, respectively, although hormone bind-
ing affinity and expression were similar to wild type RGHR
(Table II). These results indicate that aspartic acid 152 is
involved in signal transduction of RGHR and are consistent
with a recent report that Laron dwarfism occurs when aspartic
acid 152 is replaced by histidine (9). Combination of pECE-
RGHR-150,152K with pECE-RGHR-H150D and of pECE-
RGHR-D152K with pECE-RGHR-H150D resulted in comple-
mentation of luciferase induction by GH relative to pECE-
RGHR-150,152K, pECE-RGHR-D152K, and pECE-RGHR-
H150D alone, which indicates that interaction between
residues 150 and 152 is required for signal transduction. In-
deed, in the wild type RGHR, the e1 nitrogen atom of histidine
150 (bp 1) is 3.8 Å from the d1 oxygen atom of aspartic acid 152
(bp 2), forming a weak salt bridge.
In the crystal structure, the distance between the e2 nitrogen
atom of histidine 150 (bp 1) and the d oxygen atom of aspara-
gine 143 (bp 2) is 2.9 Å, which suggests a hydrogen bond
between them (4). Surprisingly, when histidine 150 was con-
verted to either aspartic acid or lysine, signaling was reduced
to less than 20% of wild type RGHR (Figs. 3 and 4), indicating
the undesirability of a full charge at this location. Examination
of the crystal structure shows that this is probably a result of3 M. J. Waters, unpublished observation.
FIG. 5. Receptor dimerization domains. A, viewed from side. a
carbon chains of the two receptor molecules are shown as yellow (bp 1)
and white (bp 2), respectively. Based on the crystal structure (Table I),
residues located in the dimerization domain are shown as red (Tyr-200,
Ser-201), blue (His-150, Asp-152), and pink (Asn-143, Ser-145, Leu-146,
and Thr-147) at the base of domains 2. B, face-on view of BP 1 dimer-
ization domain, showing residues needed for signaling in red, and those
not involved in blue. C, face-on view of BP 2 dimerization domain
showing residues needed for signaling in red, and those not involved in
yellow.
GHR Dimerization Domain5138
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
the close proximity of Asp-152 on the one hand, and steric
hindrance to the introduction of lysine on the other. Interest-
ingly, when nearby asparagine 143 was converted to lysine,
induction of c-fos promoter by GH was 67% that of wild type
RGHR, while the basal luciferase activity was 265% that of
wild type RGHR. Indeed, the small decrease of inducibility by
GH seen with this mutant may be a result of higher basal
luciferase activity rather than decreased dimerization of
RGHR. Thus, constitutive signaling by RGHR appears to occur
with this mutant. Coexpression of pECE-RGHRH150D and
pECE-RGHRN143K showed lower GH induction of luciferase
activity than pECE-RGHRN143K alone (despite similar recep-
tor number), indicating that a salt bridge between aspartic acid
150 and lysine 143 is not forming due to repulsion by Asp-152.
Examination of the crystal structure shows that lysine at 143
(bp 2) is within optimum H bond distance (3 Å) from Thr-147
(bp 1), whereas with asparagine at 143, the distance to threo-
nine 147 is too great (6.4 Å). Thus, in the Lys-143 mutant, a
new strong hydrogen bond forms, which may account for the
apparent constitutive activity.
In the model of DeVos et al. (4), the distance between the g
oxygen atom of threonine 147 (bp 1) and the d1 oxygen atom of
aspartic acid 152 (bp 2) is 2.7 Å, and the distance between the
nitrogen atom of leucine 146 (bp 1) and the g oxygen atom of
serine 201 (bp 2) is 3.1 Å. When threonine 147 was converted to
lysine, induction of luciferase activity by GH with this mutant
was 80% that of wild type RGHR and the binding affinity of
this lysine mutant was 83% that of wild type RGHR, i.e. no
significant effect was observed. Similarly, when leucine 146
was converted to lysine and to aspartic acid, induction of lucif-
erase activity by GH with these mutants were 88% and 89%
that of wild type RGHR, and binding affinity of these mutants
were 87% and 95% that of RGHR, respectively. In addition, the
combination of pECE-RGHRS201D with pECE-RGHRL146K
exhibited a lower induction of luciferase activity by GH than
pECE-RGHRL146K alone, suggesting little interaction (Table
III). These results indicate that leucine 146 and threonine 147
are not involved in signal transduction by RGHR.
There may also be an interaction between serine 145 (bp 1)
and aspartic acid 152 (bp 2), since the distance between them is
3 Å, according to the crystal structure (Table I). Accordingly,
when serine 145 was converted to cysteine or lysine, induction
of luciferase activity by GH with these mutants was 5% and
32%, respectively, and the binding affinity of these mutants
were 48% and 39% of wild type, respectively. These results
indicate that serine 145 is involved in dimerization and also
has a minor influence on affinity for hormone, possibly through
perturbation of loop 5 and 6 interactions with the hormone (4).
In summary, our results suggest that signal transduction by
RGHR, presumably as a result of dimerization, requires inter-
action between residues asparagine 143 and histidine 150,
between histidine 150 and aspartate 152, between aspartate
152 and tyrosine 200, and between serine 201 and serine 201.
The distribution of these residues is shown in Fig. 5, where it
can be seen the important residues form two small pockets, of
area less than 60 Å2. Despite the predominance of apolar res-
idues in the dimerization domain (4), it can be seen from this
figure that there is a cluster of hydrogen bonding/charge resi-
dues at the functional center of this domain.
Finally, while the results of the initial alanine scan support
the individual charge and cysteine substitutions discussed
above, pECE-RGHR-8A, pECE-RGHR-6A, pECE-RGHR-4A,
and pECE-RGHR-3A exhibited a higher basal level of lucifer-
ase activity than wild type RGHR. Indeed, it is difficult to
determine if the decrease in induction of c-fos promoter by GH
seen with these mutants results from high basal activity as a
result of enhanced dimerization or from elimination of dimer-
ization. It is certainly possible that multiple alanine substitu-
tions create a hydrophobic surface facilitating hydrophobic in-
teractions through the methyl side chains, somewhat
analogous to a leucine zipper. Consideration of Fig. 5 indicates
that such a hydrophobic pocket is likely to occur on alanine
substitution, and calculation (23, 24) of the binding free energy
for a 100-Å2 buried hydrophobic area (well within the available
surface area shown in Fig. 5) yields a value of 10–11 kJ/mol,
close to the value for the hormone-(GHBP)2 complex (25). We
attempted to determine if the increased basal luciferase was a
result of constitutive dimerization by performing the post
transfection and hormone treatment in the presence of 12.5 nM
monoclonal antibody 5, which is known to block receptor dimer-
ization (5). While this was effective in blocking signaling
through the wild type receptor, it was without effect on either
the basal activity of pECE-RGHR-8A or its residual GH induc-
tion, presumably because the epitope for monoclonal antibody 5
was destroyed, as demonstrated for the D152H Laron mutation
(9).4
In relation to the creation of constitutively active receptors,
it should be noted that this occurs both spontaneously with the
erythropoietin receptor R129C erythroleukemia mutation (18)
and can be induced by substituting cysteines at positions 132
and 132 within the putative dimerization domain of this ho-
modimerizing cytokine receptor (19). However, in the latter
case, the proportion of disulfide-bonded dimers was quite
small, and no indication of the extent of higher polymers was
given. As indicated, these prevented us from definitely conclud-
ing we had created disulfide-bonded GH receptor dimers. It is
interesting that the same residues are able to form disulfide
dimers in the erythropoietin receptor (e.g. residues 129),
whereas our complementation data suggest that different res-
idues interact across the dimerization domain, except for Ser-
201. Also, alanine substitution of four putative dimerization
domain residues with the erythropoietin receptor did not affect
proliferative signaling (19), whereas in our case, blockade of
GH induction was observed. Clearly there are major differences
between these homologous receptors. These differences empha-
size the lack of homology that exists between potential dimer-
ization domain sequences (26). This would be an advantage in
the design of specific small molecule antagonists capable of
inhibiting dimerization, hence signaling. The studies presented
here, which demonstrate that signaling can be inhibited by
modifying 5 dimerization domain residues (Ser-145, His-150,
Asp-152, Tyr-200, and Ser-201) in a tight cluster (Fig. 5), pro-
vide a target for rational design of such antagonists. In princi-
ple, this approach could find application in the creation of other
cytokine receptor antagonists for use in the treatment of a
variety of cancers.
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